BR112012031049A2 - variante isolada de um peptídeo antimicrobiano, polinucleotídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, e, método de produzir uma variante de um peptídeo antimicrobiano. - Google Patents

variante isolada de um peptídeo antimicrobiano, polinucleotídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, e, método de produzir uma variante de um peptídeo antimicrobiano.

Info

Publication number
BR112012031049A2
BR112012031049A2 BR112012031049A BR112012031049A BR112012031049A2 BR 112012031049 A2 BR112012031049 A2 BR 112012031049A2 BR 112012031049 A BR112012031049 A BR 112012031049A BR 112012031049 A BR112012031049 A BR 112012031049A BR 112012031049 A2 BR112012031049 A2 BR 112012031049A2
Authority
BR
Brazil
Prior art keywords
antimicrobial peptide
variant
isolated
nucleic acid
producing
Prior art date
Application number
BR112012031049A
Other languages
English (en)
Inventor
Raventos Segura Dorotea
Sandvang Dorthe
Hans Henrik Hoegenhaug Kristensen
Holse Mygind Per
Neve Soren
Kruse Thomas
Original Assignee
Adenium Biotech Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adenium Biotech Aps filed Critical Adenium Biotech Aps
Publication of BR112012031049A2 publication Critical patent/BR112012031049A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

variante isolada de um peptídeo antimicrobiano, polinucleotídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, e, método para produzir uma variante de um peptídeo antimicrobiano - a presente invenção diz respeito a variantes de um peptídeo antimicrobiano precursor. a presente invenção também diz respeito a polinucleotídeos que codificam as variantes; construções de ácido nucleico, vetores, e células hospedeiras que compreendem os polinucleotídeos; e métodos de usar as variantes.
BR112012031049A 2010-06-12 2011-06-10 variante isolada de um peptídeo antimicrobiano, polinucleotídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, e, método de produzir uma variante de um peptídeo antimicrobiano. BR112012031049A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP10165773 2010-06-12
EP10166483 2010-06-18
EP10176204 2010-09-10
PCT/EP2011/059689 WO2011154525A1 (en) 2010-06-12 2011-06-10 Antimicrobial peptide variants and polynucleotides encoding same

Publications (1)

Publication Number Publication Date
BR112012031049A2 true BR112012031049A2 (pt) 2017-06-20

Family

ID=44246475

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012031049A BR112012031049A2 (pt) 2010-06-12 2011-06-10 variante isolada de um peptídeo antimicrobiano, polinucleotídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, e, método de produzir uma variante de um peptídeo antimicrobiano.

Country Status (11)

Country Link
US (3) US8835604B2 (pt)
EP (1) EP2580235B1 (pt)
JP (1) JP6120769B2 (pt)
CN (1) CN103068840B (pt)
AR (1) AR081866A1 (pt)
BR (1) BR112012031049A2 (pt)
DK (1) DK2580235T3 (pt)
ES (1) ES2699734T3 (pt)
RU (1) RU2611173C2 (pt)
TW (1) TWI654933B (pt)
WO (1) WO2011154525A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200804594A (en) * 2005-12-14 2008-01-16 Novozymes As Polypeptides having antimicrobial activity and polynucleotides encoding same
KR20160144071A (ko) 2015-06-08 2016-12-16 이주호 토출 작동 중 역방향 유입이 방지되는 팬 보조장치
CN107188944B (zh) * 2017-06-08 2020-07-07 中国农业科学院饲料研究所 海蚯蚓抗菌肽nz17074衍生肽n6及其应用
CN107266547A (zh) * 2017-06-26 2017-10-20 北京生泰云科技有限公司 海蚯蚓抗菌肽nz17074衍生肽n2及其应用
CN112513251A (zh) * 2018-06-06 2021-03-16 辛格隆股份公司 改造的抗微生物肽
RU2721273C1 (ru) * 2019-04-22 2020-05-18 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Пептид никомицин из морского кольчатого червя nicomache minor, обладающий антимикробным и противоопухолевым действием.
CN110754400B (zh) * 2019-10-28 2022-04-26 长江大学 一种提高黄鳝苗种人工孵化率的方法
EP4198045A1 (en) * 2021-12-16 2023-06-21 Université de Lille Antimicrobial peptides, variants and chemical analogues thereof and their uses

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK122686D0 (da) 1986-03-17 1986-03-17 Novo Industri As Fremstilling af proteiner
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
PT97110B (pt) 1990-03-23 1998-11-30 Gist Brocades Nv Processo para catalisar reaccoes acelaraveis por enzimas, mediante adicao ao meio reaccional de sementes de plantas transgenicas e para obtencao das referidas sementes
US6395966B1 (en) 1990-08-09 2002-05-28 Dekalb Genetics Corp. Fertile transgenic maize plants containing a gene encoding the pat protein
IL99552A0 (en) 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
DE4343591A1 (de) 1993-12-21 1995-06-22 Evotec Biosystems Gmbh Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
DK0765394T3 (da) 1994-06-03 2001-12-10 Novozymes As Oprensede Myceliopthora-laccaser og nukleinsyrer der koder for disse
AU2705895A (en) 1994-06-30 1996-01-25 Novo Nordisk Biotech, Inc. Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
AU6188599A (en) 1998-10-26 2000-05-15 Novozymes A/S Constructing and screening a dna library of interest in filamentous fungal cells
CN100532561C (zh) 1999-03-22 2009-08-26 诺沃奇梅兹有限公司 新的葡糖淀粉酶及编码它的核酸序列
US7151204B2 (en) 2001-01-09 2006-12-19 Monsanto Technology Llc Maize chloroplast aldolase promoter compositions and methods for use thereof
ATE375388T1 (de) 2001-07-27 2007-10-15 Us Gov Health & Human Serv Systeme zur stellengerichteten in-vivo-mutagenese mit oligonukleotiden
EA012569B1 (ru) * 2004-02-24 2009-10-30 Коммонвелт Сайентифик Энд Индастриал Рисёч Организейшн Пептид насекомых, обладающий противогрибковой и/или антибактериальной активностью, и способы его применения
AR052947A1 (es) * 2005-03-18 2007-04-11 Novozymes As Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que codifican para los mismos
DE602006013330D1 (de) * 2005-08-26 2010-05-12 Novozymes Adenium Biotech As Polypeptide mit antimikrobieller aktivität und diese kodierende polynukleotide

Also Published As

Publication number Publication date
US20150031601A1 (en) 2015-01-29
CN103068840B (zh) 2016-11-16
CN103068840A (zh) 2013-04-24
TWI654933B (zh) 2019-04-01
RU2611173C2 (ru) 2017-02-21
AR081866A1 (es) 2012-10-24
US8835604B2 (en) 2014-09-16
TW201206353A (en) 2012-02-16
JP6120769B2 (ja) 2017-04-26
RU2012148781A (ru) 2014-07-20
US20110306750A1 (en) 2011-12-15
JP2013531491A (ja) 2013-08-08
WO2011154525A1 (en) 2011-12-15
ES2699734T3 (es) 2019-02-12
EP2580235B1 (en) 2018-10-17
DK2580235T3 (en) 2019-01-28
EP2580235A1 (en) 2013-04-17
US20160158317A1 (en) 2016-06-09

Similar Documents

Publication Publication Date Title
BR112012031049A2 (pt) variante isolada de um peptídeo antimicrobiano, polinucleotídeo isolado, construção de ácido nucleico, vetor de expressão, célula hospedeira, e, método de produzir uma variante de um peptídeo antimicrobiano.
AR113177A2 (es) Polipéptidos que tienen actividad de lisozima y polinucleótidos que los codifican
MX337984B (es) Variantes de alfa amilasa y polinucleotidos que codifican la misma.
MX353621B (es) Variantes de alfa-amilasa.
IN2014CN00597A (pt)
MX355356B (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MX2014004539A (es) Variantes de alfa-amilasa y polinucleotidos que codifican las mismas.
MX2014002415A (es) Variantes de glucoamilasas y polinucleotidos que las codifican.
MX352023B (es) Variantes de alfa-amilasa con estabilidad mejorada.
MX351762B (es) Variantes de glucoamilasas y polinucleotidos que las codifican.
MX2013007853A (es) Polipeptidos que tienen actividad de celobiohidrolasa y polinucleotidos que codifican los mismos.
WO2013119302A3 (en) Gh61 polypeptide variants and polynucleotides encoding same
MX356647B (es) Polipeptidos que tienen actividad de fosfolipasa c y polinucleotidos que codifican los mismos.
MX2021013104A (es) Variantes de lipasa y polinucleotidos que las codifican.
MX2012009705A (es) Variantes de lisozima y polinucleotidos que codifican la misma.
MX337913B (es) Polipeptidos que tienen actividad celobiohidrolasa y polinucleotidos que codifican los mismos.
MX2015000312A (es) Polipeptidos que tienen actividad lipasa y polinucleotidos que los codifican.
WO2013096603A3 (en) Cellobiohydrolase variants and polynucleotides encoding same
MX349517B (es) Polipeptidos que tienen actividad de proteasa y polinucleotidos que codifican los mismos.
WO2013163590A3 (en) Gh61 polypeptide variants and polynucleotides encoding same
WO2014195356A3 (en) Alpha-amylase variants and polynucleotides encoding same
MX2014001594A (es) Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican.
IN2014CN03187A (pt)
MX350391B (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.
MX2015007775A (es) Polipeptidos que poseen actividad proteasa y polinucleotidos que los codifican.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements